Topics / Medicinal Products

A subject heading for parliamentary questions

Medicinal Products

1,233 questions from 132 TDs, between 22 January 2025 and 22 October 2026.

1,233
questions
1,229 written, 4 oral
132
TDs have asked
11
parties and groups
Independents counted together
4
departments asked

Questions per month

The record holds no questions for August, when the Dáil does not sit.

Jan 2025Oct 2026
Show as a table
MonthQuestions
January 202517
February 202566
March 202528
April 202535
May 202543
June 202558
July 202556
August 20250
September 202536
October 202538
November 202558
December 202527
January 202618
February 202670
March 2026142
April 202687
May 2026156
June 2026127
July 202682
August 20260
September 202662
October 202627

Who asks, by party

The party each TD belonged to on the day, in alphabetical order. Parties differ a lot in size, and members of the Government answer questions rather than ask them, so this shows who raised it, not how much a party cares about it.

  • 100% RDR2 from 1 TD · 1 seat today
  • Aontú15 from 2 TDs · 2 seats today
  • Fianna Fáil298 from 31 TDs · 48 seats today
  • Fine Gael171 from 23 TDs · 38 seats today
  • Green Party9 from 1 TD · 1 seat today
  • Independent81 from 11 TDs · 15 seats today
  • Independent Ireland209 from 3 TDs · 4 seats today
  • Labour Party107 from 11 TDs · 11 seats today
  • People Before Profit-Solidarity37 from 3 TDs · 3 seats today
  • Sinn Féin210 from 36 TDs · 39 seats today

The TDs who asked most

Members of the Government answer questions rather than ask them. Each question counts once.

  1. 196
  2. 75
  3. 43
  4. 42
  5. 39
  6. 26
  7. 26
  8. 26

Asked of

Debated under the same heading

Debates whose official heading is exactly these words.

The questions

James O'Connor Written 27 May 2025 · to Health
767. Deputy James O'Connor asked the Minister for Health if urgent approval will be granted for vyloy (zolbetuximab) which is used for certain types of gastric and gastroesophageal junction cancers (details supplied); and if she will make a statement on the matter. [27575/25]
Pádraig O'Sullivan Written 27 May 2025 · to Health
769. Deputy Pádraig O'Sullivan asked the Minister for Health if she will consider for reimbursement the new treatment VYLOY (zolbetuximab), which is used for certain types of gastric and gastroesophageal junction cancers; and if she will make a statement on the matter. [27585/25]
Pádraig Rice Written 27 May 2025 · to Health
800. Deputy Pádraig Rice asked the Minister for Health if a drug will be made available to patients for certain types of gastric and gastroesophageal junction cancers under the HSE reimbursement scheme (details supplied); and if she will make a statement on the matter. [27684/25]
Holly Cairns Written 27 May 2025 · to Health
802. Deputy Holly Cairns asked the Minister for Health the reason vyloy, also called zolbetuximab, (details supplied) is not currently reimbursed by the HSE under the drug payment scheme despite being approved by the European Medicines Agency; and if she will make a statement on the matter. [27689/25]
Pat Buckley Written 27 May 2025 · to Health
805. Deputy Pat Buckley asked the Minister for Health for a fast-tracked review of vyloy (zolbetuximab), which is used for certain types of gastric and gastroesophageal junction cancers, for inclusion in the HSE reimbursement scheme. [27703/25]
Pat Buckley Written 27 May 2025 · to Health
806. Deputy Pat Buckley asked the Minister for Health for greater clarity and urgency in addressing access to approved cancer medications in Ireland; and if she will make a statement on the matter. [27704/25]
George Lawlor Written 21 May 2025 · to Health
167. Deputy George Lawlor asked the Minister for Health if she will address the ongoing shortage of estradot (estradiol transdermal) patches in Ireland; if she is aware that women are frequently having to change pharmacies, travel to Northern Ireland, or arrange private courier services to access their prescribed hormone replacement therapy (HRT); if she will comment on reports that general practitioners are reluctan…
Sorca Clarke Written 21 May 2025 · to Health
184. Deputy Sorca Clarke asked the Minister for Health for an update on the review of atropine 0.01%; if consideration has been given to making it available for myopia control; and if she will make a statement on the matter. [26316/25]
Sorca Clarke Written 21 May 2025 · to Health
185. Deputy Sorca Clarke asked the Minister for Health the criteria for which atropine 0.01% eye drops, prescribed for myopia, to limit the risk of damage to eyes and potentially detached retinas is not on licence, and therefore not covered by the drug payment scheme. [26317/25]
Duncan Smith Written 21 May 2025 · to Health
189. Deputy Duncan Smith asked the Minister for Health if there are any proposals to include Venlafaxine in the free HRT scheme, given this is commonly prescribed for women who cannot take HRT due to previous cancer, as this medication is an alternative prescribed for the many women unable to take HRT; and if she will make a statement on the matter. [26372/25]
Paul Murphy Written 20 May 2025 · to Health
782. Deputy Paul Murphy asked the Minister for Health if she is aware of the fact that a number of new medicines are being made available through private healthcare providers, while public patients are made to wait for these to become available (details supplied); if she will instruct her Department to ensure that lifesaving medication is made available to all patients; and if she will make a statement on the matter.…
Brian Stanley Written 20 May 2025 · to Health
787. Deputy Brian Stanley asked the Minister for Health if there are any plans to add Ozempic and Saxenda to the list of medications available under the drugs payment scheme for weight loss programmes; and if she will make a statement on the matter. [25199/25]
James Geoghegan Written 20 May 2025 · to Health
788. Deputy James Geoghegan asked the Minister for Health to examine concerns in correspondence (details supplied) and outline the measures she is taking to address these. [25210/25]
James Geoghegan Written 20 May 2025 · to Health
789. Deputy James Geoghegan asked the Minister for Health for an update on her engagements with representatives of pharmacists in relation to the free HRT scheme; if she will consider raising the dispensing fee for each HRT item (details supplied); and if she will make a statement on the matter. [25211/25]
John Lahart Written 20 May 2025 · to Health
791. Deputy John Lahart asked the Minister for Health further to Parliamentary Question No. 235 of 2 October 2024, her views on whether funding earmarked for new medicines was spent on existing medicines; whether she will issue a directive to the HSE to ensure all funding earmarked for new medicines is spent exclusively for that purpose; and if she will make a statement on the matter. [25228/25]
David Cullinane Written 20 May 2025 · to Health
806. Deputy David Cullinane asked the Minister for Health the number of community pharmacies that have signed up to the upcoming HRT programme proposed by her Department, by county of those who have done so. [25303/25]
Michael Collins Written 20 May 2025 · to Health
808. Deputy Michael Collins asked the Minister for Health further to Parliamentary Question No. 798 of 18 February 2025, for a further update on the progression of the recommended policy regarding 'controlled drugs' Ava's protocol, as per the inquest on 5 December 2024; and if she will make a statement on the matter. [25333/25]
Seán Ó Fearghaíl Written 20 May 2025 · to Health
814. Deputy Seán Ó Fearghaíl asked the Minister for Health further to Parliamentary Question No. 177 of 18 May 2022, when voretigene neparvovec luxturna will be added to the reimbursement list in line with the Health Act 2013 and the national framework agreed with the pharmaceutical industry under which a company must submit an application to the HSE to have a new medicine approved; and if she will make a statement o…
Pádraig O'Sullivan Written 20 May 2025 · to Health
828. Deputy Pádraig O'Sullivan asked the Minister for Health if he will make the freestyle libre 2 system available on medical card to those using both metformin and insulin; and if she will make a statement on the matter. [25471/25]
Niamh Smyth Written 15 May 2025 · to Health
309. Deputy Niamh Smyth asked the Minister for Health if she will review correspondence (details supplied) in relation to the proposed HRT scheme; and if she will make a statement on the matter. [24913/25]
Claire Kerrane Written 15 May 2025 · to Health
325. Deputy Claire Kerrane asked the Minister for Health further to Parliamentary Question No. 2211 of 29 April 2025, if a timeline or target exists for the provision of intravitreal injections for macular degeneration in a community setting; the specific steps which have been taken to date in actioning this recommendation from the 2018 Eye Services Review; and if she will make a statement on the matter. [24973/25]
John Lahart Written 15 May 2025 · to Health
328. Deputy John Lahart asked the Minister for Health to outline the position with regard to access to medicines by pharmacists, as indicated at a recent conference; if she is satisfied with the supply chain for all drugs; and if she will make a statement on the matter. [25002/25]
Jennifer Whitmore Written 14 May 2025 · to Health
189. Deputy Jennifer Whitmore asked the Minister for Health the number of community pharmacies she has written to regarding the provision of free HRT; the uptake she has had on her offer to date, on a county-by-county basis, in tabular form; and if she will make a statement on the matter. [24629/25]
Jennifer Whitmore Written 14 May 2025 · to Health
190. Deputy Jennifer Whitmore asked the Minister for Health whether her Department has provided pharmacists with a full list of medications to be covered under the free HRT scheme; and if she will make a statement on the matter. [24630/25]
Jennifer Whitmore Written 14 May 2025 · to Health
191. Deputy Jennifer Whitmore asked the Minister for Health whether appropriate IT systems are in place to allow for the free HRT scheme to be rolled out efficiently, and for individual pharmacies to be reimbursed by the State in a timely manner; and if she will make a statement on the matter. [24631/25]